NewAmsterdam Pharma Co N.V. (NAMS) stock
NAMSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NAMSW
$19.74+0.35 (+1.81%)
Close on Nov 18, 2026Market cap $2.36BP/E –Yield –
NewAmsterdam Pharma pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
No pe ratio figures for NewAmsterdam Pharma
NewAmsterdam Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?